Gregory Gin | IR |
Brian Leuthner | Co-Founder, CEO, President and Director |
Andrew Saik | Chief Financial Officer |
Albert Marchio | Interim CFO and Chief Accounting & Administrative Officer |
Jason Butler | JMP Securities LLC |
Barbara Kotei | Crédit Suisse |
Paul Matteis | Leerink Partners LLC |
Antonio Arce | H.C. Wainwright & Co |
Good day, ladies and gentlemen. Welcome to the Edge Therapeutics Third Quarter 2017 Conference Call. [Operator Instructions].
As a reminder, this conference call is being recorded. I'll now introduce your host for today's conference, Greg Gin of Edge Therapeutics.